Findings from the HELEN-006 trial suggest a potential shift in neoadjuvant treatment practices for patients with HER2-positive early breast cancer, specifically using nab-paclitaxel to reduce ...

President-elect Donald Trump has tapped Dr Jay Bhattacharya, a Stanford health economist, to lead the National Institutes of Health.

Imkeldi is supplied as a strawberry-flavored oral solution in a 140 mL, child-resistant, tamper-evident bottle.

To run the US Centers for Disease Control and Prevention, Trump has turned to David Weldon, MD, a long-time internist who interrupted his medical career to represent a Florida district for 7 terms in ...

Clinical factors associated with an increased risk of psychological distress included younger age, female sex, advanced pathological/tumor stage, and preoperative setting.

"In a country with the wealth and resources of the USA, it is intolerable that so many are living in conditions and with health outcomes akin to those of an entirely different country," the ...

A retrospective study revealed differences in metastasis patterns and treatment utilization by ethnicity among patients with breast cancer and brain metastasis.

Adding pembrolizumab to radiotherapy and surgery can improve disease-free survival in patients with certain types of sarcoma.

The approval is supported by data from the COBLT study, FDA dockets and public information, and an observational database.

ALA fluorescence-guided surgery improved the rate of gross total resection in a phase 3 trial of patients with glioblastoma.

CNSide can aid the diagnosis and management of leptomeningeal metastases in patients with cancer, a new study suggests.

Mehmet Oz, President-elect Donald Trump’s choice to run the Centers for Medicare & Medicaid Services, recently held investments in health care, tech, and food companies that would pose significant ...